The Food and Drug Administration’s approval of the cancer drug Blenrep late Thursday offered some vindication for GSK, which ...

FDA approves cancer drug belantamab mafodotin-blmf for relapsed multiple myeloma in combination with bortezomib and dexamethasone.

The New York-listed healthcare giant is keen to recoup the £1.2bn it paid to buy the supplier of the electronic patient ...

The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...

A recent study shows adults with cardiovascular disease (CVD) have a higher risk of developing shingles. People who have two ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 248,000 of its own ordinary shares as part ...

The Catawba County Public Health Community Health Workers program is dedicated to ensuring that all families in Catawba ...

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive ...

GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK plc announced the purchase of 340,000 of its own ordinary shares as part of its ongoing ...

The "Saudi Arabia Adult Vaccine Market Report by Disease wise - Adult Vaccines Market, Disease wise - Numbers of Vaccinated Adults, States and Company Analysis, 2025-2033" report has been added to ...